CIK 0001527352 · <br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 8-K Event Other events
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $3.10 ($3,100)
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $2.98 ($2,980)
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Medical Officer bought 1,500 shares at $2.70 ($4,050)
- 4 Open-market buy Chief Medical Officer bought 3,000 shares at an average $2.57 ($7,700)
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market buy Chief Medical Officer bought 500 shares at $2.19 ($1,095)
- 4/A Grant or award 10% owner acquired 700,000 shares (grant or award)
Page 5 of 11 · 206 filings